Celldex Therapeutics buy Morgan Stanley
Start price
09.05.25
/
50%
€16.30
Target price
09.05.26
€38.34
Performance (%)
19.02%
Price
08:00
?
Summary
This prediction is currently active. The prediction currently has a performance of 19.02%. This prediction currently runs until 09.05.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 1.587% | 1.587% |
| iShares Core DAX® | 1.066% | -0.525% |
| iShares Nasdaq 100 | -0.493% | -4.055% |
| iShares Nikkei 225® | -2.028% | 6.911% |
| iShares S&P 500 | -0.103% | -2.366% |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its price target lowered by analysts at Morgan Stanley from $46.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat